Vyvanse is a blockbuster drug that makes over $1 billion a year, and binge-eating disorder
sales are expected to add $200-$300 million annually.
The FDA further added that Vyvanse's safety and effectiveness in treating binge-eating disorder
were evaluated in clinical studies including 724 people.
While some insurers have covered binge-eating disorder
, the lack of official recognition put coverage in question and may have dissuaded some from seeking treatment.
The public has only recently become aware of binge-eating disorder
and since it is not yet included in the DSM, research on it is still very limited.
is identified by eating when you are not physically hungry, or eating rapidly and secretly, and feeling out of control around food.
Community surveys have estimated that between 2 percent and 5 percent of Americans experience binge-eating disorder
in a 6-month period.
Updated to reflect the latest DSM categorizations, the new edition includes coverage of binge-eating disorder
and examines pharmacological as well as psychotherapeutic approaches to treating eating disorders.
6, 2014 /PRNewswire-iReach/ -- Binge-eating disorder
, designated in 2013 by the American Psychiatric Association as a diagnosis in its Diagnostic and Statistical Manual of Mental Disorders-V, is associated with substantial lifelong impairments comparable to those of bulimia nervosa, according to a recent World Health Organization study based on community epidemiological surveys conducted in 12 nations worldwide.
Meanwhile, the likelihood for miscarriage was more than triple for binge-eating disorder
Not a single medication is approved for treatment of binge-eating disorder
, but that could change if the favorable results of an ongoing phase III randomized trial of lisdexamfetamine mirror those of a recently completed phase II study.
To recognize whether you or a friend have an eating disorder, you'll need to know enough to identify the most common disorders - anorexia nervosa, bulimia nervosa and binge-eating disorder
of Chicago) describe an adapted form of dialectical behavioral therapy--originally developed by Marsha Linehan in 1993 for individuals engaging in recurrent suicidal behavior who meet criteria for borderline personality disorder--that has been modified for treatment of clients with binge-eating disorder
and/or symptoms of bulimia nervosa.